Clinical Trial Update: A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 crossover trial evaluating vorinostat in patients with advanced cancer has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Cancer Relapsed, Advanced Cancer Refractory | Phase 1 | Status: COMPLETED | Results posted: 2010-02-15